In an announcement on April 29, Tether, the issuer of popular stablecoin USDT, revealed its strategic investment of $200 million into Blackrock Neurotech, a leading neural implant company.
In an announcement on April 29, Tether, the issuer of popular stablecoin USDT, revealed its strategic investment of $200 million into Blackrock Neurotech, a leading neural implant company. This investment positions Tether as the majority stakeholder in the innovative firm.
The transaction was facilitated through Tether Evo, a newly established division focused on exploring the intersection of human potential and technology. This investment follows Tether's recent introduction of four new business divisions, including Tether Data, Tether Finance, Tether Power, and Tether Edu, signaling the company's expansion into diverse areas of business.
Founded in 2008, Blackrock Neurotech has been at the forefront of developing advanced brain-computer interfaces for individuals with paralysis, loss of function, and neurological disorders. Through Blackrock Neurotech's groundbreaking brain interface technology, patients have been able to operate robotic arms, control wheelchairs, communicate messages, and even browse the internet using the power of their thoughts.
Paolo Ardoino, CEO of Tether, expressed his enthusiasm for the collaboration, stating: “Blackrock Neurotech is just the beginning of our journey through Tether Evo to venture into projects that redefine the boundaries of what’s possible at the intersection of technological innovation and human potential. Tether has long believed in nurturing emerging technologies that have transformative capabilities, and the Brain-Computer-Interfaces of Blackrock Neurotech have the potential to open new realms of communication, rehabilitation, and cognitive enhancement.”
Tether's $200 million investment aims to support the commercialization and wider adoption of medical solutions that have already shown success in more than 40 individuals. The funding will also contribute to enhancing Blackrock Neurotech's research and development efforts, ensuring its position as a major player in the field of brain-computer interfaces in the future. The long-term focus of the partnership is on human evolution and pushing the boundaries of what technology can achieve.
This article contains links to third-party websites or other content for information purposes only (“Third-Party Sites”). The Third-Party Sites are not under the control of CoinMarketCap, and CoinMarketCap is not responsible for the content of any Third-Party Site, including without limitation any link contained in a Third-Party Site, or any changes or updates to a Third-Party Site. CoinMarketCap is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement, approval or recommendation by CoinMarketCap of the site or any association with its operators.
This article is intended to be used and must be used for informational purposes only. It is important to do your own research and analysis before making any material decisions related to any of the products or services described. This article is not intended as, and shall not be construed as, financial advice.
The views and opinions expressed in this article are the author’s [company’s] own and do not necessarily reflect those of CoinMarketCap.
